Company Filing History:
Years Active: 2020-2023
Title: Noriko Yokose: Innovator in Cyclin-Dependent Kinase Research
Introduction
Noriko Yokose is a prominent inventor based in Kobe, Japan. She has made significant contributions to the field of biochemistry, particularly in the area of cyclin-dependent kinases (CDKs). With a total of 2 patents, her work has the potential to impact cancer treatment and drug sensitivity assessments.
Latest Patents
Yokose's latest patents include a method for determining sensitivity to cyclin-dependent kinase 4/6 inhibitors. This method involves comparing the activity of CDK4 and CDK6 in a sample from a subject against a threshold level. If the activity is below this threshold, the subject is determined to be insensitive to the inhibitor. Another notable patent is for a cyclin-dependent kinase substrate, which includes a polypeptide with a specific amino acid sequence. This substrate is designed to enhance the understanding of CDK functions and their interactions.
Career Highlights
Noriko Yokose is currently employed at Sysmex Corporation, where she continues her research and development efforts. Her work at Sysmex has positioned her as a key player in the advancement of diagnostic technologies related to cancer therapies.
Collaborations
Yokose collaborates with esteemed colleagues such as Kenta Noda and Masatoshi Suganuma. These partnerships enhance her research capabilities and contribute to the innovative environment at Sysmex Corporation.
Conclusion
Noriko Yokose's contributions to the field of cyclin-dependent kinases exemplify her dedication to advancing medical science. Her innovative patents and collaborative efforts are paving the way for future breakthroughs in cancer treatment.